Detalles de la búsqueda
1.
Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study.
Front Immunol
; 8: 625, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28620382
Resultados
1 -
1
de 1
1
Próxima >
>>